In support of this, selective inhibition of HDAC1/2 results effective in inhibiting HH signaling and reducing tumor growth in Shh-dependent medulloblastoma mouse models through increased acetylation of Gli1 at Lys518 (Coni et al., 2017). Here, SHH is linked to medulloblastoma.